3/3
04:46 pm
incr
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
Low
Report
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
2/19
07:00 am
incr
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
Medium
Report
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
2/19
07:00 am
incr
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
Medium
Report
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
12/18
04:36 pm
incr
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/12
04:16 pm
incr
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.